IART's free cash flow for Q1 2024 was $291.00K. For the 2024 fiscal year, IART's free cash flow was decreased by $-31.14M and operating cash flow was $15.76M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ 88.68M	$ 264.47M	$ 312.43M	$ 203.83M	$ 231.43M	$ 199.68M
Investing Cash Flow	$ -82.64M	$ -58.58M	$ -161.44M	$ -68.07M	$ -162.67M	$ -49.70M
Financing Cash Flow	$ 135.64M	$ -251.95M	$ -98.23M	$ 121.63M	$ -8.77M	$ -180.87M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 1.36B	$ 456.66M	$ 513.45M	$ 470.17M	$ 198.91M	$ 138.84M
Income Tax Paid Supplemental Data	-	-	-	-	-	$ 10.40K
Interest Paid Supplemental Data	-	-	-	-	-	$ 58.30K
Issuance Of Capital Stock	-	-	-	$ 0.00	$ 0.00	$ 349.59M
Issuance Of Debt	$ 408.82M	$ -107.80M	$ -100.00M	$ 746.50M	$ 236.90M	$ 171.20M
Repayment Of Debt	$ -108.58M	$ -148.55M	$ -125.50M	$ -545.25M	$ -246.10M	$ -660.00M
Free Cash Flow	$ 30.89M	$ 233.27M	$ 264.41M	$ 139.94M	$ 96.90M	$ 121.94M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Integra Lifesciences Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing